National Infusion Center Association
- Vascular Access
- Uncategorized
- Training
- Storytelling
- Sponsored
- Scheduling
- Risk Management
- Regulatory Comment
- Providers
- Press Release
- Pharmacology
- Patients
- Operations
- Legislative Comment
- Legal Risk Mitigation
- Legal
- Insurance
- Infusion Patients
- In The News
- Emergency Resources
- Disease Management
- Data Management
- Chronic Illness
- Billing
- Artificial Intelligence
- Advocacy
- Access Issues
The Corporate Practice of Medicine (“CPOM”) doctrine is one of the relatively significant legal issues to consider for corporate entities seeking to provide healthcare services.
By: Patrick LaVoie, CEO and Founder of Thrivory, Inc. Navigating Financial Options to Improve Your Infusion Center’s Performance Infusion centers play a vital role in the […]
Infusion providers focused on providing excellent patient care often ask themselves, “How do I design a clinical training program that focuses on clinician competency and excellent patient care?”
The National Infusion Center Association (NICA) Standards and Accreditation Program has earned the Infusion Nurses Society (INS) Seal of Approval. This prestigious endorsement serves as a […]
“ERT home infusions: Everything you need to know” This article describes how ERT, or Enzyme replacement therapy, is currently the only available type of approved Pompe disease […]
The NICA Accreditation Program and the National Infusion Center Association are proud to announce that FloMed Infusion has earned the National Infusion Center Association (NICA) Accreditation […]
The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Intrafusion by McKesson, Neurological Sciences of Orlando (NSO) has earned the […]
The NICA Accreditation Program and the National Infusion Center Association are proud to announce that Ivira Infusions has earned the National Infusion Center Association (NICA) Accreditation […]
The National Infusion Center Association (NICA), the Global Colon Cancer Association (GCCA), and the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a complaint in U.S. […]
The National Infusion Center Association (NICA) announces its collaboration with COSACO, a community health organization based in Puerto Rico, to improve access to COVID-19 monoclonal antibody […]
“Tracking Down Antibody Treatment Is A Challenge For COVID-19 Patients” This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her […]
“Q&A: Monoclonal Antibodies for COVID-19” In this Q&A interview with Jason C. Gallagher, PharmD, Clinical Professor and Clinical Specialist at Temple University, NICA is mentioned as […]